UK based Health Tech Partnership company
International MedTech Gateway
We help global healthcare technology and medical device innovators enter and scale across the UK and European markets.
What we do
UK and EU Market Access
Stakeholder mapping, introductions, engagement planning, and procurement pathway guidance.
We specialise in stakeholder mapping to identify key players in your target market. This strategic approach ensures that you connect with the right individuals and organisations.
Commercial Representation
UK and Europe agent support, partner and distributor identification, sales enablement, and pipeline management. Effective engagement planning is crucial for market entry. At globalmedtechlimited.com, we help you develop a tailored plan that aligns with your business goals and the expectations of our stakeholders.
Regulatory Readiness
Readiness checks for UK and Europe requirements and assurance expectations, supporting a safe route to adoption.
Partnerships & Distribution
Connecting suppliers with UK delivery partners and specialist distributors as appropriate. Our mission is to facilitate smooth market access for businesses looking to enter the UK and EU. We aim to provide the tools and knowledge necessary for successful engagement and procurement pathways.
Who we support
For UK and International Suppliers
- Enter the UK and Europe market with a structured go-to-market approach
- Understand typical NHS/private buyer expectations
- Build a credible evidence and assurance narrativ
- Identify early adopter sites and commercial partnersStakeholder mapping, introductions, engagement planning, and procurement pathway guidance.
For UK/EU Buyers & Partners
- Discover innovative international solutions
- Access curated suppliers with readiness screening
- Engage on pilots, evaluation and deployment support routes
- Strengthen supply chain options with credible partners
Our Approach and 5-steps Framework
Step 1 — Initial Assessment and Qualification (Week 0–1)
We start with a structured discovery session to understand your product, intended use, commercial objectives, and UK readiness. This helps us confirm whether the opportunity is viable and which route to market is most appropriate (NHS, private sector, distributor-led, pilot-first, or partnership-first)
What we cover:
- Product overview and intended use (including target users and care setting)
- Current traction (markets served, reference customers, outcomes achieved)
- UK market fit: where it sits in the pathway and who the likely buyers are
- Regulatory status and readiness (e.g., device classification, UKCA/CE positioning, MHRA status where applicable)
- Data protection and security considerations (where the solution handles personal data)
- Commercial model: pricing approach, margins/commission expectations, delivery responsibilities
- Capacity and responsiveness: who will support demos, technical queries, and buyer engagement
Outputs:
- Initial “go / conditional go / hold” recommendation
- Agreed target segment(s) and priority use cases
- Draft route-to-market hypothesis (e.g., pilot site approach vs distributor approach)
Step 2 — Readiness Pack and UK/EU Positioning (Week 1–2)
If the opportunity qualifies, we help build a clear, UK/EU-ready narrative and the core materials needed to engage buyers and partners confidently. This is where we translate the product story into language that resonates with UK and EU stakeholders (clinical, operational, digital/IT, procurement, and governance).
What we develop:
- UK/EU value proposition and “why now” positioning
- Target buyer personas and stakeholder map (clinical lead, CCIO/CNIO, digital, IG, procurement, operational sponsors)
- Key messages for: patient benefit, productivity/flow, safety, evidence, assurance and implementation
- A “minimum evidence pack” checklist tailored to your category and setting
- A basic risk and assurance view (what questions buyers will ask and how to answer them)
Typical deliverables:
- One-page product overview (UK/EU buyer version)
- Slide deck for meetings and demos (short and long variants)
- FAQs for procurement/IT/IG questions
- Implementation outline (high-level onboarding, training, support model)
- Initial list of required artefacts (regulatory, security, IG, clinical evidence) where relevant
Outcome:
A professional, consistent “supplier pack” that enables high-quality engagement without reinventing messaging for every meeting.
Step 3 — Stakeholder Engagement and Introductions (Week 2–6)
We then begin targeted engagement with relevant UK stakeholders and organisations, aligned to the agreed route to market. This can include NHS providers, private providers, integrated care systems, clinical networks, procurement frameworks, distributors, and specialist delivery partners.
What we do:
- Identify and prioritise target organisations (and the right individuals within them)
- Warm introductions via relevant networks where possible
- Arrange exploratory calls, demos, and deeper technical sessions
- Support responses to typical buyer questions (implementation, governance, evidence, support model)
- Maintain a structured engagement log and pipeline view
Where appropriate, we also support:
- Identifying “early adopter” and pilot-friendly sites
- Positioning within conferences/expos and stakeholder events
- Partner/distributor scouting and initial due diligence
Outputs:
- A managed engagement pipeline (targets, status, next steps)
- Meeting notes and actions captured promptly
- Feedback loop to refine messaging and improve conversion
Step 4 — Commercial Pathway and Contracting Approach (Week 4–10)
Once interest is validated, we work with you to move from engagement to a viable commercial pathway. This includes shaping the agency/distribution model, confirming responsibilities, and reducing friction for procurement.
What we address:
- Whether we proceed as an agent/market access partner, a reseller/distribution partner, or a hybrid model
- Commercial terms: commission triggers, margins, pricing structures, payment terms
- Clarifying roles: who provides support, training, warranty handling, and escalation
- Basic contracting readiness: data processing, confidentiality, buyer terms, and governance expectations
- Procurement route options: direct contracting, framework routes, distributor-led routes, pilot agreements
Outputs:
- Agreed commercial pathway and responsibilities matrix (who does what)
- Heads of terms for representation/agency (or distributor terms if relevant)
- A procurement-ready “what buyers need” checklist (to accelerate closing)
Outcome:
A structured, credible route from “interest” to “contract-ready”, reducing delays and misunderstandings.
Step 5 — Pilot Delivery Support, Scale and Ongoing Account Management (Ongoing)
After a pilot or initial deployment begins, we support ongoing account management to ensure momentum is maintained and learning is converted into scalable growth. This phase is about operational follow-through and building repeatable success.
What we do:
- Coordinate stakeholder touchpoints and maintain alignment (clinical, digital, operational, procurement)
- Support pilot governance (objectives, success measures, feedback loops)
- Capture outcomes, testimonials and case-study materials (where permission is granted)
- Identify expansion opportunities (additional wards/services, neighbouring organisations, wider partner routes)
- Maintain an ongoing relationship rhythm with you and the UK/EU stakeholders
Outputs:
- Pilot/early deployment learning log and improvement actions
- Updated pitch materials backed by real feedback
- Expansion plan and next-quarter pipeline target
Outcome:
A move from “single-site interest” to a repeatable, scalable commercial model.
What makes us different
1/4
Copyright © globalmedtechlimited.com - All Rights Reserved.
Company number: 16991064
office address: Suite Ra01 195-197 Wood Street, London, United Kingdom, E17 3NU
info@globalmedtechlimited.com Ph: 00447985158738, 00447884080704
Powered by Innovatehealthconsulting.com
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.